Oral-Systemic Mechanisms in Diagnostic Medicine: A Syndromic and Translational Review
The oral cavity's diagnostic potential remains underutilized in mainstream medicine, despite being a dynamic interface between systemic physiology and environmental exposure. This review proposes a mechanism-based framework that repositions oral structures and secretions as bio-reflective zones, thereby mirroring pathophysiological processes across endocrine, cardiovascular, renal, neurological, and genetic domains. By integrating evidence from salivary biomarkers, mucosal alterations, craniofacial anomalies, and radiographic features, we demonstrate how oral diagnostics can serve as early indicators of systemic dysfunction. Mechanistic clues to multisystem disorders are provided by oral phenotypes, with a particular emphasis on syndromic convergence. The manuscript also underscores the potential for implementation in the fields of interdisciplinary screening protocols, AI-assisted oral imaging, and salivary biosensing. It is imperative to take diagnostic equity into account when examining the potential of oral evaluations to address disparities in underserved populations, particularly in situations where systemic testing is unavailable. By integrating clinical, molecular, and imaging-based insights, this review enhances oral diagnostics from adjunctive observations to actionable tools in the detection and monitoring of systemic diseases, thereby promoting a paradigm.
References
1. Dongiovanni P, Meroni M, Casati S, Goldoni R, Thomaz DV, Kehr NS, et al. Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. Int J Oral Sci. 2023;15(1):27.
2. Surdu A, Foia LG, Luchian I, Trifan D, Tatarciue MS, Scutariu MM, et al. Saliva as a diagnostic tool for systemic diseases-a narrative review. Medicina (Kaunas). 2025;61(2):243.
3. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000;13(4):547-58.
4. Ahonen H, Pakpour A, Norderyd O, Broström A, Fransson EI, Lindmark U. Applying world dental federation theoretical framework for oral health in a general population. Int Dent J. 2022;72(4):536-44.
5. D'Aiuto F, Suvan J, Siripaiboonpong N, Gatzoulis MA, D'Aiuto F. The root of the matter: linking oral health to chronic diseases prevention. Int J Cardiol Congenit Heart Dis. 2025;19:100574.
6. Lumelsky N. Oral-systemic immune axis: crosstalk controlling health and disease. Front Dent Med. 2023;3: doi: 10.3389/fdmed.2022.1106456
7. Zhao M, Xie Y, Gao W, Li C, Ye Q, Li Y. Diabetes mellitus promotes susceptibility to periodontitis novel insight into the molecular mechanisms. Front Endocrinol (Lausanne). 2023;14:1192625.
8. Thomas JT, Joseph B, Varghese S, Kamalasanan Vijayakumari B, Sorsa T, Mauramo M, et al. Salivary advanced glycated end products, their receptors, and aMMP-8 in periodontitis patients with varying glycemic levels: a cross-sectional study. J Periodontol. 2025;96(8):835-47.
9. de Molon RS, Rossa C Jr, Thurlings RM, Cirelli JA, Koenders MI. Linkage of periodontitis and rheumatoid arthritis: current evidence and potential biological interactions. Int J Mol Sci. 2019;20(18):4541.
10. Hashimoto H, Hashimoto S, Shimazaki Y. Functional impairment and periodontitis in rheumatoid arthritis. Int Dent J. 2022;72(5):641-7.
11. Zian Z, Bouhoudan A, Mourabit N, Azizi G, Bennani Mechita M. Salivary cytokines as potential diagnostic biomarkers for systemic lupus erythematosus disease. Mediators Inflamm. 2021;2021(1):8847557.
12. Rodsaward P, Prueksrisakul T, Deekajorndech T, Edwards SW, Beresford MW, Chiewchengchol D. Oral ulcers in juvenile-onset systemic lupus erythematosus: a review of the literature. Am J Clin Dermatol. 2017;18(6):755-62.
13. Infantino M, Nagy E, Bizzaro N, Fischer K, Bossuyt X, Damoiseaux J. Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus. J Transl Autoimmun. 2022;5:100139.
14. Khozeimeh F, Shakerin H, Daghaghzadeh H, Najarzadegan F, Golestannejad Z, Adibi P. Oral manifestations in inflammatory bowel disease: a cross-sectional study in Isfahan. Dent Res J (Isfahan). 2021;18:4.
15. Atarbashi-Moghadam S, Lotfi A, Atarbashi-Moghadam F. Pyostomatitis vegetans: a clue for diagnosis of silent crohn's disease. J Clin Diagn Res. 2016;10(12):ZD12-ZD13.
16. Nijakowski K, Surdacka A. Salivary Biomarkers for diagnosis of inflammatory bowel diseases: a systematic review. Int J Mol Sci. 2020;21(20):7477.
17. Abdelbary MMH, Hatting M, Bott A, Dahlhausen A, Keller D, Trautwein C, et al. The oral-gut axis: salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease. Front Cell Infect Microbiol. 2022;12:1010853.
18. Al-Janaby H, El-Sakka H, Masood M, Ashani W, Mendis W, Slack-Smith L, Parsons R, et al. Xerostomia and salivary gland hypofunction in patients with oral lichen planus before and after treatment with topical corticosteroids. Open Dent J. 2017;11(1):155-63.
19. Pijpe J, Kalk WW, Bootsma H, Spijkervet FK, Kallenberg CG, Vissink A. Progression of salivary gland dysfunction in patients with Sjögren's syndrome. Ann Rheum Dis. 2007;66(1):107-12.
20. Decup F, Rihab B, Nocturne G, Gosset M. The role of dental professionals in identifying patients with a suspected primary Sjögren's syndrome and suggestions for prevention and treatment of oral complications: a narrative review. Heliyon. 2025;11(13):e43564.
21. Kamounah S, Tayob N, Chiang S, Wei F, Park JK, Kwon HM, et al. Immunoassay detects salivary anti-SSA/Ro-52 autoantibodies in seronegative patients with primary Sjögren's syndrome. Immunohorizons. 2023;7(7):554-61.
22. Jeffers L, Webster-Cyriaque JY. Viruses and salivary gland disease (SGD). Adv Dent Res. 2011;23(1):79-83.
23. Ito K, Izumi N, Funayama S, Nohno K, Katsura K, Kaneko N, et al. Characteristics of medication-induced xerostomia and effect of treatment. PLoS One. 2023;18(1):e0280224.
24. Daly C. Oral and dental effects of antidepressants. Aust Prescr. 2016;39(3):84.
25. Treviño-Tijerina MC, Garza-Villarreal J, Sáenz-Rangel S, Cruz-Fierro N. Dental dilemmas in blood disorders: navigating oral health in hematological diseases. Int J Appl Dent Sci. 2023;9(4):283-9.
26. Zisis V, Zisis S, Anagnostou E, Dabarakis N, Poulopoulos A, Andreadis D. Gingival enlargement can constitute the only diagnostic sign of leukemia: report of an unusual case. Cureus. 2023;15(10):e47959.
27. Quispe RA, Aguiar EM, de Oliveira CT, Neves ACX, Santos PSDS. Oral manifestations of leukemia as part of early diagnosis. Hematol Transfus Cell Ther. 2022;44(3):392-401.
28. Khammissa RAG, Fourie J, Masilana A, Lawrence S, Lemmer J, Feller L. Oral manifestations of thrombocytopaenia. Saudi Dent J. 2018;30(1):19-25.
29. Hans M, Hans VM, Kahlon N, Sagar M, Pandey AK, Das A. Gustatory dysfunction and oral ulceration in COVID-19 patients: a cross sectional study. Dent Res J (Isfahan). 2022;19:43.
30. Iranmanesh B, Khalili M, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID-19 disease: a review article. Dermatol Ther. 2021;34(1):e14578.
31. Zhu L, Zhou C, Chen S, Huang D, Jiang Y, Lan Y, et al. Osteoporosis and alveolar bone health in periodontitis niche: a predisposing factors-centered review. Cells. 2022;11(21):3380.
32. Ng PYB, Donley M, Hausmann E, Hutson AD, Rossomando EF, Scannapieco FA. Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol Med Microbiol. 2007;49(2):252-60.
33. Karunakaran N, Maiti S, Jayaraman S, Paulraj J. Assessment of bone turnover markers prior to dental implant placement for osteoporosis patient- a case- control study. Ann Dent Spec. 2023;11(2):57-61.
34. JP, Nisha VA, Gs A, Ca P, Mm V. Oral manifestations in a renal osteodystrophy patient a case report with review of literature. J Clin Diagn Res. 2014;8(8):ZD28-30.
35. Dagistan S, Miloglu O, Caglayan F. Changes in jawbones of male patients with chronic renal failure on digital panoramic radiographs. Eur J Dent. 2016;10(1):64-8.
36. Gendron R, Grenier D, Maheu-Robert LF. The oral cavity as a reservoir of bacterial pathogens for focal infections. Microbes Infect. 2000;2(8):897-906.
37. Bumm C V, Folwaczny M. Infective endocarditis and oral health-a narrative review. Cardiovasc Diagn Ther. 2021;11(6):1403-15.
38. Del Giudice C, Vaia E, Liccardo D, Marzano F, Valletta A, Spagnuolo G, et al. Infective endocarditis: a focus on oral microbiota. Microorganisms. 2021;9(6):1218.
39. Leishman SJ, Do HL, Ford PJ. Cardiovascular disease and the role of oral bacteria. J Oral Microbiol. 2010;2: doi: 10.3402/jom.v2i0.5781.
40. Peng X, Cheng L, You Y, Tang C, Ren B, Li Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci. 2022;14(1):14.
41. Wu Y, Lan Y, Mao J, Shen J, Kang T, Xie Z. The interaction between the nervous system and the stomatognathic system: from development to diseases. Int J Oral Sci. 2023;15(1):34.
42. Srivanitchapoom P, Pandey S, Hallett M. Drooling in Parkinson's disease: a review. Parkinsonism Relat Disord. 2014;20(11):1109-18.
43. De Bartolo MI, Belvisi D, Mancinelli R, Costanzo M, Caturano C, Leodori G, et al. A systematic review of salivary biomarkers in Parkinson's disease. Neural Regen Res. 2024;19(12):2613-25.
44. Chemaly D, Lefrançois A, Pérusse R. Oral and maxillofacial manifestations of multiple sclerosis. J Can Dent Assoc. 2000;66(11):600-5.
45. Al Johani K, Fudah M, Al-Zahrani M, Abed H, Srivastava KC, Shrivastava D, et al. Multiple sclerosis-a demyelinating disorder and its dental considerations a literature review with own case report. Brain Sci. 2023;13(7):1009.
46. Gooding AJ, Packer CD, Pensiero AL. Zinc Deficiency-induced hypogeusia in a patient with refractory iron-deficiency anemia: a case report. Cureus. 2019;11(12):e6365.
47. Ansari A, Anwarhussain Mulla S, Patil A, Bedia AS, More S, Jaiswal H, et al. Oral manifestations associated with gastrointestinal diseases-a review. Bioinformation. 2025;21(3):383-9.
48. Cengiz S, Cengiz MI, Saraç YS. Dental erosion caused by gastroesophageal reflux disease: a case report. Cases J. 2009;2:8018.
49. Păduraru G, Ghiga G, Gimiga N, Lupu VV, Bozomitu L, Adam Răileanu A, et al. Oral manifestations of anorexia in adolescent patients. Rom J Oral Rehabil. 2024;16(1):686-92.
50. Kothiwale S. An oral clinician's perspective towards Peutz Jegher's syndrome-a case report. J Prob Health. 2015;3(1):1-2.
51. Lešić S, Ivanišević Z, Špiljak B, Tomas M, Šoštarić M, Včev A. The impact of vitamin deficiencies on oral manifestations in children. Dent J (Basel). 2024;12(4):109.
52. Samad A, Mohan N, Balaji RVS, Augustine D, Patil SG. Oral manifestations of plummer-vinson syndrome: a classic report with literature review. J Int Oral Health. 2015;7(3):68-71.
53. Vanam C, Thammisetty DP. Case report on plummer vinson syndrome. Int J Basic Clin Pharmacol. 2019;8(10):2334.
54. Chaluvaraj R, Ashley PF, Parekh S. Scurvy presenting primarily as gingival manifestation in a young child: a diagnostic dilemma. BMJ Case Rep. 2022;15(6):e249113.
55. Botelho J, Machado V, Proença L, Delgado AS, Mendes JJ. Vitamin D deficiency and oral health: a comprehensive review. Nutrients. 2020;12(5):1471.
56. Jagelavičienė E, Vaitkevičienė I, Šilingaitė D, Šinkūnaitė E, Daugėlaitė G. The relationship between vitamin D and periodontal pathology. Medicina (Kaunas). 2018;54(3):45.
57. Sheetal A, Hiremath VK, Patil AG, Sajjansetty S, Kumar SR. Malnutrition and its oral outcome a review. J Clin Diagn Res. 2013;7(1):178-80.
58. Al-Maweri SA, Tarakji B, Al-Sufyani GA, Al-Shamiri HM, Gazal G. Lip and oral lesions in children with down syndrome. A controlled study. J Clin Exp Dent. 2015;7(2):e284-8.
59. Goud EVSS, Gulati S, Agrawal A, Pani P, Nishant K, Pattnaik SJ, et al. Implications of Down's syndrome on oral health status in patients: a prevalence-based study. J Family Med Prim Care. 2021;10(11):4247-52.
60. Nirmala S. Dental concerns of children with down's syndrome-an overview. J Pediatr Neonatal Care. 2017;6(3):248.
61. Bergendal B. Orodental manifestations in ectodermal dysplasia-a review. Am J Med Genet A. 2014;164A(10):2465-71.
62. Morandini AC, Adeogun O, Black M, Holman E, Collins K, James W, et al. Ectodermal dysplasia: a narrative review of the clinical and biological aspects relevant to oral health. Front Pediatr. 2025;13:1523313.
63. Elgasmi FE, Rahmaoui M, Elarabi S, Badre B. Dental management of ectodermal dysplasia: a report of two clinical cases. Cureus. 2025;17(5):e84031.
64. Pan CY, Tseng YC, Lan TH, Chang HP. Craniofacial features of cleidocranial dysplasia. J Dent Sci. 2017;12(4):313-8.
65. Roberts T, Stephen L, Beighton P. Cleidocranial dysplasia: a review of the dental, historical, and practical implications with an overview of the South African experience. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(1):46-55.
66. Bostanci B, Korkut E, Unlu N. Dental findings in marfan syndrome: a case report. J Istanb Univ Fac Dent. 2017;51(2):61-7.
67. Wotjiuk F, Hyon I, Dajean-Trutaud S, Badran Z, Prud'homme T. Dental management of neurofibromatosis type 1: a case report and literature review. Int J Clin Pediatr Dent. 2019;12(6):577-81.
68. Javed F, Ramalingam S, Ahmed HB, Gupta B, Sundar C, Qadri T, et al. Oral manifestations in patients with neurofibromatosis type-1: a comprehensive literature review. Crit Rev Oncol Hematol. 2014;91(2):123-9.
69. Droubi L, Laflouf M, Tolibah YA, Comisi JC. Apert syndrome: dental management considerations and objectives. J Oral Biol Craniofac Res. 2022;12(3):370-5.
70. Vadiati Saberi B, Shakoorpour A. Apert syndrome: report of a case with emphasis on oral manifestations. J Dent (Tehran). 2011;8(2):90-5.
71. Martelli-Junior H, Coletta RD, Miranda RT, Barros LM de, Swerts MS, Bonan PR. Orofacial features of Treacher Collins syndrome. Med Oral Patol Oral Cir Bucal. 2009;14(7):E344-8.
72. Chang CC, Steinbacher DM. Treacher Collins syndrome. Semin Plast Surg. 2012;26(2):83-90.
73. Ahiko N, Baba Y, Tsuji M, Horikawa R, Moriyama K. Investigation of maxillofacial morphology and oral characteristics with Turner syndrome and early mixed dentition. Congenit Anom (Kyoto). 2019;59(1):11-7.
74. Szilágyi A, Keszthelyi G, Nagy G, Madlena M. Oral manifestations of patients with Turner syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89(5):577-84.
75. Poornima P, Patil PS, Subbareddy V V, Arora G. Dentofacial characteristics in William's syndrome. Contemp Clin Dent. 2012;3(Suppl 1):S41-4.
76. Wong D, Ramachandra SS, Singh AK. Dental management of patient with Williams syndrome - a case report. Contemp Clin Dent. 2015;6(3):418-20.
77. Vavetsi K, Panagopoulou O, Koromantzos P, Fryssira H, Bobetsis SA, Emmanouil D, et al. Oral manifestations of nine individuals with Williams syndrome: a case series. Spec Care Dentist. 2024;44(2):438-49.
78. Teixeira CS, Felippe MCS, Felippe WT, Silva-Sousa YTC, Sousa-Neto MD. The role of dentists in diagnosing osteogenesis imperfecta in patients with dentinogenesis imperfecta. J Am Dent Assoc. 2008;139(7):906-14.
79. Biria M, Abbas FM, Mozaffar S, Ahmadi R. Dentinogenesis imperfecta associated with osteogenesis imperfecta. Dent Res J (Isfahan). 2012;9(4):489-94.
80. Ventura L, Verdonk SJE, Zhytnik L, Ridwan-Pramana A, Gilijamse M, Schreuder WH, et al. Dental abnormalities in osteogenesis imperfecta: a systematic review. Calcif Tissue Int. 2024;115(5):461-79.
81. Gupta M, Gupta M, Abhishek. Oral conditions in renal disorders and treatment considerations-a review for pediatric dentist. Saudi Dent J. 2015;27(3):113-9.
82. Deepika ADN, Sridevi K, Buduru K, Malempati S, Ramya K, Sahi BK. Oral manifestations of chronic renal failure patients on hemodialysis. Uttar Pradesh J Zool. 2023;44(20):12-9.
83. Oyetola EO, Owotade FJ, Agbelusi GA, Fatusi OA, Sanusi AA. Oral findings in chronic kidney disease: implications for management in developing countries. BMC Oral Health. 2015;15:24.
84. Garcia-Rios P, Rodríguez-Lozano FJ, Pérez-Guzmán N. Oral findings linked to chronic kidney disease: a comprehensive systematic review. J Clin Med. 2025;14(12):4380.
85. Dembowska E, Jaroń A, Gabrysz-Trybek E, Bladowska J, Trybek G. Oral mucosa status in patients with end-stage chronic kidney disease undergoing hemodialysis. Int J Environ Res Public Health. 2023;20(1):835.
86. Kaushik A, Reddy SS, Umesh L, Devi BKY, Santana N, Rakesh N. Oral and salivary changes among renal patients undergoing hemodialysis: a cross-sectional study. Indian J Nephrol. 2013;23(2):125-9.
87. Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc. 2006;137(3):313-21.
88. Ding C, Ji X, Chen X, Xu Y, Zhong L. TNF-a gene promoter polymorphisms contribute to periodontitis susceptibility: evidence from 46 studies. J Clin Periodontol. 2014;41(8):748-59.
89. Albagieh H, Alshehri AZ, Alduraywishi AS, Aldaws A, AlBalawi SS, Abu Shaqqaf HF, et al. Evaluation of salivary diagnostics: applications, benefits, challenges, and future prospects in dental and systemic disease detection. Cureus. 2025;17(1):e77520.
90. Meleti M, Cassi D, Vescovi P, Setti G, Pertinhez TA, Pezzi ME. Salivary biomarkers for diagnosis of systemic diseases and malignant tumors: a systematic review. Med Oral Patol Oral Cir Bucal. 2020;25(2):e299-e310.
91. Mirzaii-Dizgah I, Riahi E. Salivary high-sensitivity cardiac troponin T levels in patients with acute myocardial infarction. Oral Dis. 2013;19(2):180-4.
92. Floriano PN, Christodoulides N, Miller CS, Ebersole JL, Spertus J, Rose BG, et al. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem. 2009;55(8):1530-8.
93. Giusti L, Baldini C, Ciregia F, Giannaccini G, Giacomelli C, De Feo F, et al. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis?. Proteomics Clin Appl. 2010;4(3):315-24.
94. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum. 2007;56(11):3588-600.
95. Rao PV, Reddy AP, Lu X, Dasari S, Krishnaprasad A, Biggs E, et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res. 2009;8(1):239-45.
96. Vered M, Peleg O, Taicher S, Buchner A. The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts. J Oral Pathol Med. 2009;38(7):597-604.
97. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park N, et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology. 2010;138(3):949-57.
98. Ahmed M, Carrascosa LG, Wuethrich A, Mainwaring P, Trau M. An exosomal- and interfacial-biosensing based strategy for remote monitoring of aberrantly phosphorylated proteins in lung cancer cells. Biomater Sci. 2018;6(9):2336-41.
99. Xie Z, Yin X, Gong B, Nie W, Wu B, Zhang X, et al. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Cancer Prev Res (Phila). 2015;8(2):165-73.
100. Koizumi T, Shetty V, Yamaguchi M. Salivary cytokine panel indicative of non-small cell lung cancer. J Int Med Res. 2018;46(9):3570-82.
101. Freitas AJA de, Causin RL, Varuzza MB, Calfa S, Hidalgo Filho CMT, Komoto TT, et al. Liquid biopsy as a tool for the diagnosis, treatment, and monitoring of breast cancer. Int J Mol Sci. 2022;23(17):9952.
102. Chen Y, Zheng J, Su L, Chen F, Zhu R, Chen X, et al. Increased salivary microRNAs that regulate DJ-1 gene expression as potential markers for Parkinson's disease. Front Aging Neurosci. 2020;12:210.
103. Hisamatsu D, Masuoka H, Takeshige-Amano H, Kurokawa R, Ogata Y, Suda W, et al. Acetylcholinesterase inhibitors considerably affect the salivary microbiome in patients with Alzheimer's disease. iScience. 2025;28(6):112593.
104. Spielmann N, Wong D. Saliva: diagnostics and therapeutic perspectives. Oral Dis. 2011;17(4):345-54.
105. Zhang L, Xiao H, Wong DT. Salivary biomarkers for clinical applications. Mol Diagn Ther. 2009;13(4):245-59.
106. Javaid MA, Ahmed AS, Durand R, Tran SD. Saliva as a diagnostic tool for oral and systemic diseases. J Oral Biol Craniofac Res. 2016;6(1):67-76.
107. Senf B, Yeo WH, Kim JH. Recent advances in portable biosensors for biomarker detection in body fluids. Biosensors (Basel). 2020;10(9):127.
108. Kazimierczak N, Sultani N, Chwarścianek N, Krzykowski S, Janiszewska-Olszowska J, Serafin Z, et al. Detection accuracy of an AI platform for dental treatment features on panoramic radiographs-tooth and patient-level analyses. Sci Rep. 2025;16(1):2436.
109. Zhang YL, Zhang XK, Fu TG. Artificial intelligence reshapes early oral cancer screening: from image recognition to risk prediction. Int J Surg. 2025;111(12):9874-5.
110. Mahesh Batra A, Reche A. A new era of dental care: harnessing artificial intelligence for better diagnosis and treatment. Cureus. 2023;15(11):e49319.
111. Al-Khalifa KS, Ahmed WM, Azhari AA, Qaw M, Alsheikh R, Alqudaihi F, et al. The use of artificial intelligence in caries detection: a review. Bioengineering (Basel). 2024;11(9):936.
112. Kaushik R, Rapaka R. AI-driven evolution in teledentistry: a comprehensive overview of technology and clinical applications. Dent Rev. 2025;5(2):100154.
113. Inchingolo AD, Marinelli G, Fiore A, Balestriere L, Carone C, Inchingolo F, et al. Diagnostic support in dentistry through artificial intelligence: a systematic review. Bioengineering (Basel). 2025;12(11):1244.
114. Farooqi OA. Independent validation of dental AI: a local imperative for trust and safety. Int Dent J. 2026;76(1):104029.
115. Koçak B, Ponsiglione A, Stanzione A, Bluethgen C, Santinha J, Ugga L, et al. Bias in artificial intelligence for medical imaging: fundamentals, detection, avoidance, mitigation, challenges, ethics, and prospects. Diagn Interv Radiol. 2025;31(2):75-88.
116. Limaye S, Shreenivas A, Patil D, Sambath J, George IA, Parab A, et al. Liquid biopsy a pivotal test to help navigate clinical decisions at a precision center in India!. J Liq Biopsy. 2025;9:100323.
117. Caputo V, Ciardiello F, Della Corte CM, Martini G, Troiani T, Napolitano S. Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer. Explor Target Antitumor Ther. 2023;4(1):102-38.
118. Starska-Kowarska K. Salivaomic biomarkers an innovative approach to the diagnosis, treatment, and prognosis of oral cancer. Biology (Basel). 2025;14(7):852.
119. Connal S, Cameron JM, Sala A, Brennan PM, Palmer DS, Palmer JD, et al. Liquid biopsies: the future of cancer early detection. J Transl Med. 2023;21(1):118.
120. Adeoye J, Su Y. Artificial intelligence in salivary biomarker discovery and validation for oral diseases. Oral Dis. 2024;30(1):23-37.
121. Li Y, Ou Y, Fan K, Liu G. Salivary diagnostics: opportunities and challenges. Theranostics. 2024;14(18):6969-90.
122. Patil S, Albogami S, Hosmani J, Mujoo S, Kamil MA, Mansour MA, et al. Artificial intelligence in the diagnosis of oral diseases: applications and pitfalls. Diagnostics (Basel). 2022;12(5):1029.